[市場調查報告書] OTC醫藥品的BRIC（巴西・俄國・印度・中國）市場

Abstract

1 INTRODUCTION

This report contains easily comparable data on market value, volume, segmentation and market share for the BRIC countries OTC Pharmaceuticals market, plus full fiveyear market forecasts. It examines future problems, innovations and potential growth areas within the market.

What is this report about?

This report is a part of Datamonitor' s BRIC Industry Guide series, which includes comprehensive category data and analysis across all major industry sectors. These incisive reports include key data points, charts and expert analysis on a global, regional and country basis.

Who is the target reader?

This report should make essential reading for anyone involved in the OTC Pharmaceuticals market - plus anyone considering expansion into OTC Pharmaceuticals market, or targeting customers or suppliers in the market.

This report should be read by competitive analysts, distribution managers, marketing managers, strategic planners and senior executives.

How to use this report

This introductory section sets out the report style and explains the definitions used in following chapters; chapter two gives an overview, chapters three to six consider BRIC countries chapter seven is an appendix that details Datamonitor' s research methodology.

Definitions

The OTC pharmaceuticals market values the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin, other analgesics), and other OTC healthcare products including; medicated skin products (anti-bacterials, acne treatments, anti-fungals, other medicated skin products, disinfectants), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, other tape or bandage, liquid bandages), first aid kits and other OTC healthcare products (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, motion sickness).

CHAPTER 1 INTRODUCTION

1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions

CHAPTER 2 BRIC OTC PHARMACEUTICALS INDUSTRY OUTLOOK

CHAPTER 3 OTC PHARMACEUTICALS IN BRAZIL

3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Leading Companies
3.8 Distribution
3.9 Market Forecasts
3.10 Macroeconomic Indicators

CHAPTER 4 OTC PHARMACEUTICALS IN RUSSIA

4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
4.7 Leading Companies
4.8 Distribution
4.9 Market Forecasts
4.10 Macroeconomic Indicators

CHAPTER 5 OTC PHARMACEUTICALS IN INDIA

5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share
5.6 Five Forces Analysis
5.7 Leading Companies
5.8 Distribution
5.9 Market Forecasts
5.10 Macroeconomic Indicators

CHAPTER 6 OTC PHARMACEUTICALS IN CHINA

6.1 Market Overview
6.2 Market Value
6.3 Market Segmentation I
6.4 Market Segmentation II
6.5 Market Share
6.6 Five Forces Analysis
6.7 Leading Companies
6.8 Distribution
6.9 Market Forecasts
6.10 Macroeconomic Indicators

CHAPTER 7 APPENDIX

7.1 Data Research Methodology

LIST OF TABLES

Table 1: OTC Pharmaceuticals Industry, BRIC, Revenue ($) 2004-2013 13
Table 2: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2008(e) 14
Table 3: OTC Pharmaceuticals Industry, BRIC, Revenue ($ billion) 2008-2013 15
Table 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 17
Table 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 18
Table 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 19
Table 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 20
Table 8: Key Facts: Abbott Laboratories 28
Table 9: Key Facts: Novartis AG 31
Table 10: Key Financials: Novartis AG 33
Table 11: Key Facts: GlaxoSmithKline PLC 34
Table 12: Key Financials: GlaxoSmithKline PLC 37
Table 13: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 38
Table 14: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 39
Table 15: Brazil Size of Population (million) , 2004-2008(e) 40
Table 16: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 40
Table 17: Brazil Inflation, 2004-2008(e) 41
Table 18: Brazil Exchange Rate, 2004-2008(e) 41
Table 19: Russia OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 43
Table 20: Russia OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 44
Table 21: Russia OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 45
Table 22: Russia OTC Pharmaceuticals Market Share: % Share, by Value, 2007 46
Table 23: Key Facts: Ranbaxy Laboratories Limited 53
Table 24: Key Financials: Ranbaxy Laboratories Limited 54
Table 25: Key Facts: Zentiva NV 55
Table 26: Key Financials: Zentiva NV 56
Table 27: Key Facts: KRKA 57
Table 28: Russia OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 59
Table 29: Russia OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 60
Table 30: Russia Size of Population (million) , 2004-2008(e) 61
Table 31: Russia GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 61
Table 32: Russia Inflation, 2004-2008(e) 62
Table 33: Russia Exchange Rate, 2004-2008(e) 62
Table 34: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 64
Table 35: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 65
Table 36: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 66
Table 37: India OTC Pharmaceuticals Market Share: % Share, by Value, 2007 67
Table 38: Key Facts: Dabur India Limited 75
Table 39: Key Financials: Dabur India Limited 77
Table 40: Key Facts: Zandu Pharmaceutical Works Ltd 78
Table 41: Key Financials: Zandu Pharmaceutical Works Ltd 79
Table 42: Key Facts: Cipla Ltd 80
Table 43: Key Financials: Cipla Ltd 81
Table 44: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 82
Table 45: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 83
Table 46: India Size of Population (million) , 2004-2008(e) 84
Table 47: India GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 84
Table 48: India Inflation, 2004-2008(e) 85
Table 49: India Exchange Rate, 2004-2008(e) 85
Table 50: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 87
Table 51: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 88
Table 52: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 89
Table 53: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007 90
Table 54: Key Facts: Nin Jiom Medicine Manufactory Limited 97
Table 55: Key Facts: Huangshan Tianmu Pharmaceutical Co., Ltd 98
Table 56: Key Facts: Johnson & Johnson 99
Table 57: Key Financials: Johnson & Johnson 101
Table 58: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 102
Table 59: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 103
Table 60: China Size of Population (million) , 2004-2008(e) 104
Table 61: China GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 104
Table 62: China Inflation, 2004-2008(e) 105
Table 63: China Exchange Rate, 2004-2008(e) 105

LIST OF FIGURES

Figure 1: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2013 13
Figure 2: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2008(e) 14
Figure 3: OTC Pharmaceuticals Industry, BRIC, Revenue ($) 2008-2013 15
Figure 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 17
Figure 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 18
Figure 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 19
Figure 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 20
Figure 8: Forces Driving Competition in the OTC Pharmaceuticals Market in Brazil 21
Figure 9: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Brazil 22
Figure 10: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Brazil 23
Figure 11: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Brazil 24
Figure 12: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Brazil 26
Figure 13: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Brazil 27
Figure 14: Revenues & Profitability: Novartis AG 33
Figure 15: Revenues & Profitability: GlaxoSmithKline PLC 37
Figure 16: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 38
Figure 17: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 39
Figure 18: Russia OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 43
Figure 19: Russia OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 44
Figure 20: Russia OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 45
Figure 21: Russia OTC Pharmaceuticals Market Share: % Share, by Value, 2007 46
Figure 22: Forces Driving Competition in the OTC Pharmaceuticals Market in Russia 47
Figure 23: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Russia 48
Figure 24: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Russia 49
Figure 25: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Russia 50
Figure 26: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Russia 51
Figure 27: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Russia 52
Figure 28: Revenues & Profitability: Ranbaxy Laboratories Limited 54
Figure 29: Revenues & Profitability: Zentiva NV 56
Figure 30: Russia OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 59
Figure 31: Russia OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 60
Figure 32: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 64
Figure 33: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 65
Figure 34: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 66
Figure 35: India OTC Pharmaceuticals Market Share: % Share, by Value, 2007 67
Figure 36: Forces Driving Competition in the OTC Pharmaceuticals Market in India 68
Figure 37: Drivers of Buyer Power in the OTC Pharmaceuticals Market in India 69
Figure 38: Drivers of Supplier Power in the OTC Pharmaceuticals Market in India 70
Figure 39: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in India 71
Figure 40: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in India 73
Figure 41: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in India 74
Figure 42: Revenues & Profitability: Dabur India Limited 77
Figure 43: Revenues & Profitability: Zandu Pharmaceutical Works Ltd 79
Figure 44: Revenues & Profitability: Cipla Ltd 81
Figure 45: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 82
Figure 46: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 83
Figure 47: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 87
Figure 48: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 88
Figure 49: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 89
Figure 50: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007 90
Figure 51: Forces Driving Competition in the OTC Pharmaceuticals Market in China 91
Figure 52: Drivers of Buyer Power in the OTC Pharmaceuticals Market in China 92
Figure 53: Drivers of Supplier Power in the OTC Pharmaceuticals Market in China 93
Figure 54: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in China 94
Figure 55: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in China 95
Figure 56: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in China 96
Figure 57: Revenues & Profitability: Johnson & Johnson 101
Figure 58: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 102
Figure 59: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 103

OTC醫藥品的BRIC（巴西・俄國・印度・中國）市場 - 2009年版

OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide